6–8 For example, Melander et al 6 analysed data from 10 European countries (1994–2003) and identified an increasing trend in diabetes medicines’ consumption.
← all excerpts
Low utilisation of diabetes medicines in Iran, despite their affordability (2000-2012): a time-series and benchmarking study.
1
—
—